234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,590.00
+0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 5.94x
- P/E 2027E
- 5.57x
- P/E 2028E
- 5.19x
- P/S forward
- 2.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.30x
- PEG TTM
- 0.56x
- Price / book
- 0.72x
- Price / sales
- 0.64x
- Price / cash flow
- 3.41x
Enterprise value
- Enterprise value
- KRW 186.9B
- EV / sales
- 0.74x
- EV / EBITDA
- 3.61x
- EV / EBIT
- 5.61x
- Market cap
- KRW 163.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026